Research Article
Epidemiological Features and Predictors of Mortality in Patients with COVID-19 with and without Underlying Hypertension
Table 2
The baseline characteristics of survivors and nonsurvivors in patients with COVID-19 with hypertension disease.
| | Variable | Total (n = 1927) | Survivors (n = 1674 | Nonsurvivors (n = 253) | value | | Number (%) | Number (%) | Number (%) |
| | Age, median (IQR) | 61 (50–70) | 60 (49–69) | 68 (60–78) | <0.001 |
| | Gender | | | | | | Male | 781 (40.50) | 678 (40.50) | 103 (40.71) | 0.980 | | Female | 1146 (59.5) | 996 (59.50) | 150 (59.29) |
| | Symptoms | | | | | | Fever | 1156 (59.99) | 977 (58.36) | 179 (70.75) | 0.001 | | Cough | 1028 (53.35) | 867 (51.80) | 161 (63.64) | 0.002 | | Dyspnea | 781 (40.53) | 637 (38.05) | 144 (56.92) | <0.001 | | Muscular pain | 388 (20.13) | 341 (20.37) | 47 (18.58) | 0.390 | | Sore throat | 185 (9.60) | 160 (9.56) | 25 (9.88) | 0.970 | | Disguise | 54 (2.80) | 54 (3.22) | 0 (0.00) | 0.030 | | Headache | 168 (8.72) | 152 (9.08) | 16 (6.32) | 0.120 | | Cardiovascular | 416 (21.59) | 338 (20.20) | 78 (30.80) | 0.001 | | Diabetes | 822 (42.66) | 689 (41.16) | 124 (49) | 0.04 | | Immunodeficiency | 58 (3.01) | 43 (2.57) | 15 (5.93) | 0.004 | | Chronic pulmonary disease | 87 (4.51) | 71 (4.24) | 16 (6.32) | 0.140 | | Chronic liver, kidney disease | 123 (6.38) | 105 (6.27) | 18 (7.11) | 0.640 | | Exposure to disease | 1357 (78.42) | 1195 (71.38) | 162 (64.03) | 0.010 | | Hospitalization history in ICU | 29 (1.50) | 21 (1.25) | 8 (3.16) | 0.020 |
|
|
